GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (BSP:A1RG34) » Definitions » Cyclically Adjusted Revenue per Share

argenx SE (BSP:A1RG34) Cyclically Adjusted Revenue per Share : R$0.96 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is argenx SE Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

argenx SE's adjusted revenue per share for the three months ended in Dec. 2023 was R$33.707. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$0.96 for the trailing ten years ended in Dec. 2023.

During the past 12 months, argenx SE's average Cyclically Adjusted Revenue Growth Rate was 79.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-04-29), argenx SE's current stock price is R$77.44. argenx SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was R$0.96. argenx SE's Cyclically Adjusted PS Ratio of today is 80.67.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of argenx SE was 151.79. The lowest was 74.24. And the median was 123.76.


argenx SE Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for argenx SE's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Cyclically Adjusted Revenue per Share Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.57 0.96

argenx SE Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.66 0.67 0.84 0.96

Competitive Comparison of argenx SE's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, argenx SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where argenx SE's Cyclically Adjusted PS Ratio falls into.



argenx SE Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, argenx SE's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=33.707/126.4000*126.4000
=33.707

Current CPI (Dec. 2023) = 126.4000.

argenx SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 0.241 99.080 0.307
201312 0.140 98.360 0.180
201403 0.069 99.390 0.088
201406 0.044 99.240 0.056
201409 0.299 99.960 0.378
201412 0.300 99.050 0.383
201503 0.262 99.750 0.332
201506 0.342 100.230 0.431
201509 0.638 100.500 0.802
201512 0.464 99.730 0.588
201603 0.588 100.310 0.741
201606 0.646 100.260 0.814
201609 0.894 100.570 1.124
201612 0.613 100.710 0.769
201703 0.856 101.440 1.067
201706 2.277 101.370 2.839
201709 0.896 102.030 1.110
201712 1.056 101.970 1.309
201803 0.695 102.470 0.857
201806 1.608 103.100 1.971
201809 0.279 103.950 0.339
201812 0.153 103.970 0.186
201903 3.960 105.370 4.750
201906 0.868 105.840 1.037
201909 0.831 106.700 0.984
201912 2.139 106.800 2.532
202006 0.000 107.510 0.000
202012 0.000 107.850 0.000
202103 17.843 108.870 20.716
202106 27.056 109.670 31.183
202109 0.088 110.790 0.100
202112 2.857 114.010 3.167
202203 2.237 119.460 2.367
202206 6.924 119.050 7.351
202209 13.106 126.890 13.055
202212 16.496 124.940 16.689
202303 20.546 124.720 20.823
202306 23.522 125.830 23.629
202309 28.020 127.160 27.853
202312 33.707 126.400 33.707

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


argenx SE  (BSP:A1RG34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

argenx SE's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=77.44/0.96
=80.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of argenx SE was 151.79. The lowest was 74.24. And the median was 123.76.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


argenx SE Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of argenx SE's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (BSP:A1RG34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (BSP:A1RG34) » Definitions » Cyclically Adjusted Revenue per Share
Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

argenx SE (BSP:A1RG34) Headlines

No Headlines